Health
Early trial results show Sinovac vaccine triggers immune response – Aljazeera.com
Findings another boost to hope that vaccines can bring an end to accelerating coronavirus pandemic.
Sinovac Biotechs experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, early trial results showed on Wednesday.
While the early to mid-stage trials were not designed to assess the efficacy of CoronaVac, researchers said it could provide sufficient protection, based on their experience with other vaccines and data from preclinical studies with macaques.
The study follows encouraging…
Continue Reading